These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 3006595

  • 1. [The simultaneous evaluation of serum NSE as a tumor marker in lung cancer compared with serum CEA--high sensitivity and specificity defined in the TP-FP curve].
    Shimizu K, Nose I, Koga T.
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):472-8. PubMed ID: 3006595
    [Abstract] [Full Text] [Related]

  • 2. [Clinical evaluation of serum NSE and CEA in primary lung cancer patients].
    Fukasawa T, Fujisawa T, Yamaguchi Y, Sasaki K, Shiba M, Yusa T, Sakio H, Momiki S, Ogawa T.
    Gan To Kagaku Ryoho; 1986 May; 13(5):1862-7. PubMed ID: 3010884
    [Abstract] [Full Text] [Related]

  • 3. [Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)].
    Kawahara M, Furuse K, Arai R, Tsuruta M, Kodama N, Hayashi S, Kiyota M, Kubota K, Mori T, Yamamoto S.
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):146-51. PubMed ID: 3026253
    [Abstract] [Full Text] [Related]

  • 4. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer].
    Fukuoka M, Takada M, Kamei T, Negoro S, Kusunoki Y, Matsui K, Ryu S, Sakai N, Takifuji N, Masuda N.
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108
    [Abstract] [Full Text] [Related]

  • 5. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
    Schneider J, Peltri G, Bitterlich N, Neu K, Velcovsky HG, Morr H, Katz N, Eigenbrodt E.
    Anticancer Res; 2003 Mar; 23(2A):899-906. PubMed ID: 12820320
    [Abstract] [Full Text] [Related]

  • 6. [Clinical significance of the measurement of serum neuron-specific enolase levels in patients with lung cancer].
    Yumoto Y, Shiota T, Tamai M, Okabe K, Kiura K, Shimoe T, Fujii M.
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2089-93. PubMed ID: 3013098
    [Abstract] [Full Text] [Related]

  • 7. [Serum neuron-specific enolase as a marker of lung cancers].
    Fujisawa T, Yamaguchi Y, Sasaki K, Fukazawa T, Hongo H, Ogawa T, Kimura H.
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):139-43. PubMed ID: 2981514
    [Abstract] [Full Text] [Related]

  • 8. [Clinical investigation of neuron-specific enolase, squamous cell carcinoma-related antigen and carcinoembryonic antigen in carcinoma of the lung].
    Tashiro T, Nagai H, Yamasaki H, Kuroda Y, Goto Y, Goto J, Nasu M.
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2383-8. PubMed ID: 3015044
    [Abstract] [Full Text] [Related]

  • 9. Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.
    Molina R, Auge JM, Filella X, Viñolas N, Alicarte J, Domingo JM, Ballesta AM.
    Anticancer Res; 2005 Jul; 25(3A):1773-8. PubMed ID: 16033098
    [Abstract] [Full Text] [Related]

  • 10. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
    Schneider J, Philipp M, Velcovsky HG, Morr H, Katz N.
    Anticancer Res; 2003 Jul; 23(2A):885-93. PubMed ID: 12820318
    [Abstract] [Full Text] [Related]

  • 11. [Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels].
    Kawachi S, Shimabukuro Z, Aoyama A, Yano T, Hasegawa K, Tsuboi E, Niitani H.
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2469-74. PubMed ID: 3039919
    [Abstract] [Full Text] [Related]

  • 12. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
    Pan QR, Zhang X, Xu ZF, Zheng S.
    Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
    [Abstract] [Full Text] [Related]

  • 13. Comparative studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma.
    Kohno N, Hirasawa Y, Kondo K, Fujioka S, Fujino S, Abe M, Yokoyama A, Hiwada K, Watanabe K, Nishimura J.
    Cancer Detect Prev; 1997 Feb; 21(2):124-8. PubMed ID: 9101072
    [Abstract] [Full Text] [Related]

  • 14. [The diagnostic values of CA242 combining other tumor markers for lung cancer].
    Zhang S, Ma Y, Yang X.
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):271-3. PubMed ID: 11775851
    [Abstract] [Full Text] [Related]

  • 15. [Comparative analysis of serum levels of CA-50, CA-125, CA-19.9, enolase and CEA in bronchopulmonary cancer].
    Maréchal F, Deltour G, Incatasciato C, Carpentier Y, Cattan A.
    Rev Pneumol Clin; 1987 May; 43(5):224-8. PubMed ID: 2829332
    [Abstract] [Full Text] [Related]

  • 16. [Serum neuron specific enolase (NSE) levels in patients with non small cell lung cancer].
    Shibayama T, Ohnoshi T, Ueoka H, Horiguchi T, Kodani T, Segawa Y, Maeda T, Miyatake K, Takigawa N, Kimura I.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jun; 30(6):1097-102. PubMed ID: 1324376
    [Abstract] [Full Text] [Related]

  • 17. [Tumor markers. I. Their significance in the preoperative assessment of lung neoplasms].
    Ratto GB, Capponi G, De Grandi R, Augeri C, Secco GB, Fardelli R.
    Minerva Chir; 1990 Oct 31; 45(20):1265-72. PubMed ID: 1964495
    [Abstract] [Full Text] [Related]

  • 18. [Measurement of carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific enolase in the bronchoalveolar lavage fluid in patients with peripheral lung cancer].
    Fujii M, Kiura K, Kamei H, Segawa Y.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr 31; 27(4):452-5. PubMed ID: 2552209
    [Abstract] [Full Text] [Related]

  • 19. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
    Stieber P, Dienemann H, Schalhorn A, Schmitt UM, Reinmiedl J, Hofmann K, Yamaguchi K.
    Anticancer Res; 1999 Apr 31; 19(4A):2673-8. PubMed ID: 10470218
    [Abstract] [Full Text] [Related]

  • 20. [Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE].
    Prévost A, Passemard F, Perdu D, Vallerand H, Deschamps F, Lavaud F, Larbre H.
    Rev Mal Respir; 1994 Apr 31; 11(4):379-84. PubMed ID: 7973038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.